Your browser doesn't support javascript.
loading
One-Stage Deep Inferior Epigastric Perforator Flap Salvage of Infected Tissue Expanders.
Sergesketter, Amanda R; Shammas, Ronnie L; Tian, William M; Glenney, Anne; Sisk, Geoffroy C; Hollenbeck, Scott T.
Affiliation
  • Sergesketter AR; From the Division of Plastic, Maxillofacial, and Oral Surgery, Duke University, Durham, NC.
  • Shammas RL; From the Division of Plastic, Maxillofacial, and Oral Surgery, Duke University, Durham, NC.
  • Tian WM; From the Division of Plastic, Maxillofacial, and Oral Surgery, Duke University, Durham, NC.
  • Glenney A; Drexel University School of Medicine, Philadelphia, PA.
  • Sisk GC; From the Division of Plastic, Maxillofacial, and Oral Surgery, Duke University, Durham, NC.
  • Hollenbeck ST; Department of Plastic Surgery, University of Virginia, Charlottesville, VA.
Ann Plast Surg ; 92(6S Suppl 4): S419-S422, 2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38857007
ABSTRACT

BACKGROUND:

Tissue expander-based breast reconstruction is associated with high rates of infectious complications, often leading to tissue expander explants and delays in receipt of definitive breast reconstruction and adjuvant therapy. In this study, we describe a single-stage technique where deep inferior epigastric artery perforator (DIEP) flaps are used to salvage actively infected tissue expanders among patients originally planning for free flap reconstruction.

METHODS:

In this technique, patients with tissue expander infections without systemic illness are maintained on oral antibiotics until the day of their DIEP flap surgery, at which time tissue expander explant is performed in conjunction with aggressive attempt at total capsulectomy and immediate DIEP flap reconstruction. Patients are maintained on 1-2 weeks of oral antibiotics tailored to culture data. Patients undergoing this immediate salvage protocol were retrospectively reviewed, and complications and length of stay were assessed.

RESULTS:

In a retrospective series, a total of six consecutive patients with culture-proven tissue expander infections underwent tissue expander removal and DIEP flap reconstruction in a single stage and were maintained on 7-14 days of oral antibiotics postoperatively. Within this cohort, no surgical site infections, microvascular complications, partial flap losses, reoperations, or returns to the operating room were noted within a 90-day period.

CONCLUSIONS:

Among a select cohort of patients, actively infected tissue expanders may be salvaged with free flap breast reconstruction in a single surgery with a low incidence of postoperative complications. Prospective studies are needed to evaluate the influence of this treatment strategy on costs, number of surgeries, and dissatisfaction after staged breast reconstruction complicated by tissue expander infections.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Expansion Devices / Salvage Therapy / Mammaplasty / Epigastric Arteries / Perforator Flap Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Plast Surg Year: 2024 Document type: Article Affiliation country: Nueva Caledonia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Expansion Devices / Salvage Therapy / Mammaplasty / Epigastric Arteries / Perforator Flap Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Plast Surg Year: 2024 Document type: Article Affiliation country: Nueva Caledonia
...